How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

31,885 results for

Conjunctivitis

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

1. Is there a connection between conjunctivitis and COVID-19? Full Text available with Trip Pro

Is there a connection between conjunctivitis and COVID-19? Spreading SARS-CoV-2 through ocular fluids - CEBM CEBM The Centre for Evidence-Based Medicine develops, promotes and disseminates better evidence for healthcare. Navigate this website Spreading SARS-CoV-2 through ocular fluids PDF to download Robin E Ferner, Philip I Murray, Professor of Ophthalmology, University of Birmingham, UK and Jeffrey K Aronson 20/03/2020 On behalf of the Oxford COVID-19 Evidence Service Team Centre for Evidence (...) -Based Medicine, Nuffield Department of Primary Care Health Sciences University of Oxford Correspondence to The death of the Chinese ophthalmologist in Wuhan last month raised many concerns. Here we examine one of them: the possibility that the β-coronavirus that causes COVID-19, SARS-CoV-2 (also called 2019-nCoV) can affect the eyes, causing conjunctivitis and—perhaps whether there is conjunctivitis or not—having the potential to transmit the virus via ocular fluids. SARS-COV-2 is an encapsulated

2020 Oxford COVID-19 Evidence Service

2. Acute conjunctivitis

Acute conjunctivitis Acute conjunctivitis - Symptoms, diagnosis and treatment | BMJ Best Practice You'll need a subscription to access all of BMJ Best Practice Search  Acute conjunctivitis Last reviewed: February 2019 Last updated: January 2018 Summary Symptoms include an irritated red eye with a watery or purulent discharge. Allergic conjunctivitis is usually bilateral with watery discharge and itching. Treatment for allergic conjunctivitis includes topical mast cell stabilisers (...) and antihistamines; bacterial conjunctivitis treatment includes topical antibiotics; viral conjunctivitis requires symptomatic treatment. Bacterial and viral conjunctivitis is highly contagious; measures to prevent spread of infection should be considered. Definition Conjunctivitis is the inflammation of the lining of the eyelids and eyeball caused by bacteria, viruses, allergic or immunological reactions, mechanical irritation, or medicines. American Academy of Ophthalmology. Preferred practice pattern

2018 BMJ Best Practice

3. Ciclosporin (Verkazia) - Conjunctivitis, Keratitis

Ciclosporin (Verkazia) - Conjunctivitis, Keratitis 30 Churchill Place ? Canary Wharf ? London E14 5EU ? United Kingdom An agency of the European Union Telephone +44 (0)20 3660 6000 Facsimile +44 (0)20 3660 5555 Send a question via our website www.ema.europa.eu/contact © European Medicines Agency, 2018. Reproduction is authorised provided the source is acknowledged. 20 July 2017 EMA/505143/2017 Committee for Medicinal Products for Human Use (CHMP) Assessment report Verkazia International non (...) by an inflammation of the conjunctivitis with corneal involvement and tissue remodelling including papillae formation. It was first described by Arlt in 1846 who reported 3 cases of perilimbal swelling in young patients. The association with springtime (vernal) reflects the seasonal increase in signs and symptoms of the condition, particularly the high prevalence in hot, arid environments. Affected individuals have disease flares frequently during spring months, but can have signs and symptoms year round

2018 European Medicines Agency - EPARs

7. Stiripentol (Diacomit) - for use in conjunction with clobazam and valproate as adjunctive therapy of refractory generalized tonic-clonic seizures in patients with severe myoclonic epilepsy in infancy (SMEI, Dravet syndrome)

Stiripentol (Diacomit) - for use in conjunction with clobazam and valproate as adjunctive therapy of refractory generalized tonic-clonic seizures in patients with severe myoclonic epilepsy in infancy (SMEI, Dravet syndrome) Final Appraisal Recommendation Advice No: 2617 – November 2017 Stiripentol (Diacomit ® ) 250 mg and 500 mg hard capsules; 250 mg and 500 mg powder for oral suspension in sachet Resubmission by Biocodex Additional note(s): • AWMSG considered that stiripentol (Diacomit ® (...) (where available) and the lay member perspective. This recommendation has been ratified by Welsh Government and will be considered for review every three years. Recommendation of AWMSG Stiripentol (Diacomit ® ) is recommended for use within NHS Wales for use in conjunction with clobazam and valproate as adjunctive therapy of refractory generalized tonic-clonic seizures in patients with severe myoclonic epilepsy in infancy (SMEI, Dravet syndrome) whose seizures are not adequately controlled

2017 All Wales Medicines Strategy Group

8. Conjunctivitis: Bacterial, Viral and Allergic

Conjunctivitis: Bacterial, Viral and Allergic Conjunctivitis: Bacterial, Viral and Allergic - medSask Home - College of Pharmacy and Nutrition - University of Saskatchewan Toggle Menu Search the U of S Search Conjunctivitis: Bacterial, Viral and Allergic Infectious or non-infectious Inflammation of the conjunctiva of one or both eyes The conjunctiva is the translucent covering of the sclera (white area) of the eye (bulbar area) and the undersurface of the eyelids (palpebral area) Infectious (...) causes Bacterial: Children : influenzae, S. pneumoniae, S. aureus Adults : aureus, coagulase-negative Staphylococcus organisms, H. influenzae, S. pneumoniae Viral – adenovirus (most common), herpes simplex virus, others Non-infectious Allergic – IgE-mediated reaction triggered by seasonal or perennial allergens Others – dry eye, contact lenses, chemical exposure, reaction to ophthalmic medications, trauma, etc. Common complaint – infectious conjunctivitis accounts for 30 to 40% of eye-related medical

2018 medSask

9. AdenoPlus point-of-care test for diagnosing adenoviral conjunctivitis

AdenoPlus point-of-care test for diagnosing adenoviral conjunctivitis AdenoPlus point-of-care test for diagnosing AdenoPlus point-of-care test for diagnosing adeno adenovir viral conjunctivitis al conjunctivitis Medtech innovation briefing Published: 15 December 2015 nice.org.uk/guidance/mib46 pathways Summary Summary AdenoPlus is a point-of-care test for diagnosing acute adenoviral conjunctivitis in people of all ages, and can be used in any healthcare setting. Two prospective diagnostic (...) AdenoPlus is a point-of-care test for diagnosing adenoviral conjunctivitis in people of all ages. It is designed to be used in any setting where people present with eye conditions, such as primary care, urgent care services and ophthalmology services. If adopted, it would be used as an alternative to existing laboratory tests that are currently carried out for managing persistent or high-risk infectious conjunctivitis. Effectiv Effectiveness and safety eness and safety The published evidence summarised

2015 National Institute for Health and Clinical Excellence - Advice

10. Treating Early Smooth Surface Caries with Resin Infiltrate in Conjunction with Fluoride Treatment Is an Effective Method to Prevent Caries Progression

Treating Early Smooth Surface Caries with Resin Infiltrate in Conjunction with Fluoride Treatment Is an Effective Method to Prevent Caries Progression UTCAT3141, Found CAT view, CRITICALLY APPRAISED TOPICs University: | | ORAL HEALTH EVIDENCE-BASED PRACTICE PROGRAM View the CAT / Title Treating Early Smooth Surface Caries with Resin Infiltrate in Conjunction with Fluoride Treatment Is an Effective Method to Prevent Caries Progression Clinical Question In patients with deciduous teeth, how

2017 UTHSCSA Dental School CAT Library

11. Opioids Used in Conjunction With Benzodiazepines Produce Worse Outcomes in Patients Experiencing Chronic Pain Compared To Sole Opioid Use

Opioids Used in Conjunction With Benzodiazepines Produce Worse Outcomes in Patients Experiencing Chronic Pain Compared To Sole Opioid Use UTCAT3169, Found CAT view, CRITICALLY APPRAISED TOPICs University: | | ORAL HEALTH EVIDENCE-BASED PRACTICE PROGRAM View the CAT / Title Opioids Used in Conjunction With Benzodiazepines Produce Worse Outcomes in Patients Experiencing Chronic Pain Compared To Sole Opioid Use Clinical Question For a patient experiencing chronic pain, will the use (...) of benzodiazepines with opioids, compared to opioids alone, produce better outcomes? Clinical Bottom Line For patients with chronic pain, the use of opioids in conjunction with benzodiazepines produces worse outcomes than opioids alone. This is supported by a cross-sectional study where it was noted that the combination of opioids and benzodiazepines correlated with poor mood and decreased patient function. Best Evidence (you may view more info by clicking on the PubMed ID link) PubMed ID Author / Year Patient

2017 UTHSCSA Dental School CAT Library

12. Why the Conjunction Effect Is Rarely a Fallacy: How Learning Influences Uncertainty and the Conjunction Rule Full Text available with Trip Pro

Why the Conjunction Effect Is Rarely a Fallacy: How Learning Influences Uncertainty and the Conjunction Rule In this article we explore the relationship between learning and the conjunction fallacy. The interpretation of the conjunction effect as a fallacy assumes that all observers share the same knowledge, and that nobody has access to privileged information. Such situations are actually quite rare in everyday life. Building on an existing model of surprise, we prove formally that in the more (...) typical scenarios, where observers are alert to the possibility of learning from event outcomes, the conjunction rule does not apply. Scenarios which have been engineered to produce the so-called conjunction "fallacy" (e.g., Tverksy and Kahneman, 1983) often imply subjective uncertainty and hence the possibility of learning. In Experiment 1 we demonstrate that when these scenarios are rephrased so as to eliminate subjective uncertainty, the effect is mitigated. In Experiment 2 we demonstrate that when

2018 Frontiers in psychology

13. Short- and Long-term Effects of a Mobile Phone App in Conjunction With Brief In-Person Counseling on Physical Activity Among Physically Inactive Women: The mPED Randomized Clinical Trial Full Text available with Trip Pro

Short- and Long-term Effects of a Mobile Phone App in Conjunction With Brief In-Person Counseling on Physical Activity Among Physically Inactive Women: The mPED Randomized Clinical Trial Mobile phone applications (apps) and activity trackers allow researchers to remotely deliver an intervention and monitor physical activity but have not been rigorously evaluated for longer periods.To determine whether a mobile phone-based physical activity education app, in conjunction with brief in-person

2019 EvidenceUpdates

14. Topical antihistamines and mast cell stabilisers for treating seasonal and perennial allergic conjunctivitis. Full Text available with Trip Pro

Topical antihistamines and mast cell stabilisers for treating seasonal and perennial allergic conjunctivitis. Seasonal/perennial allergic conjunctivitis is the most common allergic conjunctivitis, usually with acute manifestations when a person is exposed to allergens and with typical signs and symptoms including itching, redness, and tearing. The clinical signs and symptoms of allergic conjunctivitis are mediated by the release of histamine by mast cells. Histamine antagonists (also called (...) searches for trials. We last searched the electronic databases on 17 July 2014. We also searched the reference lists of review articles and relevant trial reports for details of further relevant publications.We included randomised controlled trials (RCTs) comparing topical antihistamine and mast cell stabilisers, alone or in combination, with placebo, no treatment or to any other antihistamine or mast cell stabiliser, or both, that examined people with seasonal or perennial allergic conjunctivitis

2015 Cochrane

15. Olopatadine for the Treatment of Allergic Conjunctivitis: A Review of the Clinical Efficacy, Safety, and Cost-Effectiveness

Olopatadine for the Treatment of Allergic Conjunctivitis: A Review of the Clinical Efficacy, Safety, and Cost-Effectiveness Olopatadine for the Treatment of Allergic Conjunctivitis: A Review of the Clinical Efficacy, Safety, and Cost-Effectiveness | CADTH.ca Find the information you need Olopatadine for the Treatment of Allergic Conjunctivitis: A Review of the Clinical Efficacy, Safety, and Cost-Effectiveness Olopatadine for the Treatment of Allergic Conjunctivitis: A Review of the Clinical (...) Efficacy, Safety, and Cost-Effectiveness Published on: March 17, 2016 Project Number: RC0756-000 Product Line: Research Type: Drug Report Type: Summary with Critical Appraisal Result type: Report Question 1. What is the clinical efficacy and safety of olopatadine for the treatment of allergic conjunctivitis? 2. What is the cost-effectiveness of olopatadine for the treatment of allergic conjunctivitis? Key Message Pooled estimates from four studies included in a systematic review showed

2016 Canadian Agency for Drugs and Technologies in Health - Rapid Review

16. Cromolyn for Allergic Conjunctivitis: Clinical Effectiveness

Cromolyn for Allergic Conjunctivitis: Clinical Effectiveness Cromolyn for Allergic Conjunctivitis: Clinical Effectiveness | CADTH.ca Find the information you need Cromolyn for Allergic Conjunctivitis: Clinical Effectiveness Cromolyn for Allergic Conjunctivitis: Clinical Effectiveness Published on: January 29, 2016 Project Number: RA0830-000 Product Line: Research Type: Drug Report Type: Reference List Result type: Report Question What is the clinical effectiveness and safety of cromolyn sodium (...) for the treatment of allergic conjunctivitis? Key Message One systematic review was identified regarding the clinical effectiveness of cromolyn sodium for allergic conjunctivitis. Tags conjunctivitis, cromolyn sodium, eye, Allergic Files Rapid Response Reference List Published : January 29, 2016 Follow us: © 2019 Canadian Agency for Drugs and Technologies in Health Get our newsletter:

2016 Canadian Agency for Drugs and Technologies in Health - Rapid Review

17. Chemical conjunctivitis and diffuse lamellar keratitis after removal of eyelash extensions Full Text available with Trip Pro

Chemical conjunctivitis and diffuse lamellar keratitis after removal of eyelash extensions There have been several reports in the literature demonstrating the adverse effects of multiple ocular cosmetic procedures, such as eyelash extensions, eyeliner tattoo, and eyelash dyeing. To our knowledge, there is limited literature on the adverse effects specifically attributed to the chemicals and process of eyelash extension removal. Our purpose is to demonstrate the possible ocular injuries from (...) misapplication of eyelash extension removal solvent.We present a unique case of a 46-year-old female with a prior history of laser assisted in-situ keratomileusis (LASIK) who presented with bilateral chemical conjunctivitis and diffuse lamellar keratitis (DLK) secondary to epithelial defects following the misapplication of eyelash extension removal gel.Given that our patient suffered significant dry eyes, corneal haze, and visual fluctuation, we believe this case underscores the importance of continuing

2018 American journal of ophthalmology case reports

18. Paraganglioma of Urinary Bladder Managed by Laparoscopic Partial Cystectomy in Conjunction with Flexible Cystoscopy: A Case Report Full Text available with Trip Pro

Paraganglioma of Urinary Bladder Managed by Laparoscopic Partial Cystectomy in Conjunction with Flexible Cystoscopy: A Case Report Background: Paraganglioma of the urinary bladder (PUB) is exceedingly rare, accounting for <0.1% of all urinary bladder tumors. Various challenging treatment options are available. Case Presentation: A 67-year-old female presented with malignant hypertension on four medications for which investigation was done. An observation of having functioning PUB was noted. She

2018 Journal of endourology case reports

19. Evaluating the efficacy of epinastine ophthalmic solution using a conjunctivitis allergen challenge model in patients with birch pollen allergic conjunctivitis. Full Text available with Trip Pro

Evaluating the efficacy of epinastine ophthalmic solution using a conjunctivitis allergen challenge model in patients with birch pollen allergic conjunctivitis. The efficacy of epinastine 0.05% ophthalmic solution for pollen allergic conjunctivitis has already been shown in a conjunctival allergen challenge (CAC) test using cedar pollen as a challenge. The present study investigated the efficacy of this solution against birch pollen conjunctivitis in a CAC test.Ten adult subjects (eight males (...) and two females) with asymptomatic birch pollen conjunctivitis were enrolled in this study. The average age of the subjects was 41.1 years. This study was conducted during a period without birch pollen dispersion. In each subject, the epinastine 0.05% ophthalmic solution was instilled in one eye, and an artificial tear fluid was instilled in the fellow eye in a double-blind manner. Five minutes or 4 h after the drug instillation, both eyes were challenged with an optimal concentration of birch pollen

2017 Allergology international : official journal of the Japanese Society of Allergology Controlled trial quality: uncertain

20. Conjunctivitis - infective

Conjunctivitis - infective Conjunctivitis - infective - NICE CKS Share Conjunctivitis - infective: Summary Infective conjunctivitis is inflammation of the conjunctiva due to viral, bacterial or parasitic infection. Viral conjunctivitis is the most common infectious conjunctivitis — the majority of cases are caused by adenoviruses. The most common bacterial causes of conjunctivitis are Streptococcus pneumoniae , Staphylococcus aureus and Haemophilus influenzae . Hyperacute conjunctivitis (...) is a rapidly developing severe conjunctivitis typically caused by infection with Neisseria gonorrhoeae. Ophthalmia neonatorum (ON) is conjunctivitis occurring within the first four weeks of life — it can be infectious or non-infectious. Acute conjunctivitis is usually self-limiting and rarely causes loss of vision. Viral conjunctivitis usually resolves within 7 days. Epidemic keratoconjunctivitis (caused by adenoviruses) can lead to visual loss and light sensitivity. Bacterial conjunctivitis typically

2018 NICE Clinical Knowledge Summaries

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>